Clinical trials sponsored by Amsterdam UMC, location VUmc

Phase breakdown

Conditions studied

Recruiting trials led by Amsterdam UMC, location VUmc

• BPA in CTEPD Without PH
  NCT06090838 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease
  NCT06416345 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
  NCT06983054 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
  NCT06068582 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 67 Years · Sex: All (male and female) · 1 location
• Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS
  NCT05900271 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 4 locations
• Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
  NCT07782164 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lateral Nodal Recurrence in Rectal Cancer
  NCT04486131 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
  NCT06567197 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
  NCT06384560 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
  NCT05834855 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
  NCT04772768 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)
  NCT06658522 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
  NCT05350722 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female · 7 locations

Common questions

How many trials is Amsterdam UMC, location VUmc recruiting for?

Amsterdam UMC, location VUmc is the lead sponsor of 13 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.